Showing results (71-80 of 365) with videos related to
Sort By:
Pageof 37
Acta Medica Scandinavica. Supplementum|January 1, 1976
Effects of metabolic and pharmacologic interventions on myocardial infarct size following coronary occlusionP R Maroko, E BraunwaldThe American Journal of Cardiology|January 30, 1987
Effects of calcium antagonists on infarcting myocardiumR A Kloner, E BraunwaldCirculation|December 1, 1982
The stunned myocardium: prolonged, postischemic ventricular dysfunctionE Braunwald, R A KlonerAmerican Heart Journal|April 30, 2017
Randomized Evaluation of the Effects of Anacetrapib through Lipid-modification (REVEAL)-A large-scale, randomized, placebo-controlled trial of the clinical effects of anacetrapib among people with established vascular disease: Trial design, recruitment, and baseline characteristics, L Bowman, F Chen, et al.The New England Journal of Medicine|October 31, 1996
Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromesE M Antman, M J Tanasijevic, B Thompson, et al.The American Journal of Cardiology|November 18, 1991
Ventricular enlargement and remodeling following acute myocardial infarction: mechanisms and managementE Braunwald, M A PfefferThe American Journal of Cardiology|November 18, 1991
Ventricular enlargement following infarction is a modifiable processM A Pfeffer, E BraunwaldAmerican Heart Journal|April 30, 1999
Safety assessment of single-bolus administration of TNK tissue-plasminogen activator in acute myocardial infarction: the ASSENT-1 trial. The ASSENT-1 InvestigatorsF Van de Werf, C P Cannon, A Luyten, et al.Pageof 37